2012 Scrip Asia 100 - Japan expands global footprint
This article was originally published in Scrip
Executive Summary
Japan’s pharmaceutical industry is in the midst of a defining period. The sector has evolved dramatically over the past decade, as companies attempt to gain ground on their western peers in meeting the demands of global healthcare markets. While the top ten companies in Japan pharma are dominant within their domestic market, generating more than half of overall prescription pharma revenues in Japan, a range of factors have provided the impetus for companies to expand their global footprint.